
Tirzepatide: A Comprehensive Review of its Clinical Efficacy, Safety, and Future Implications Beyond Type 2 Diabetes
Abstract Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising therapeutic agent for type 2 diabetes mellitus (T2DM). Beyond its potent glycemic control and weight […]